HK1156076A1 - Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides - Google Patents

Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides

Info

Publication number
HK1156076A1
HK1156076A1 HK11110363.5A HK11110363A HK1156076A1 HK 1156076 A1 HK1156076 A1 HK 1156076A1 HK 11110363 A HK11110363 A HK 11110363A HK 1156076 A1 HK1156076 A1 HK 1156076A1
Authority
HK
Hong Kong
Prior art keywords
urlc10
lung cancers
peptide vaccines
cancers expressing
expressing ttk
Prior art date
Application number
HK11110363.5A
Other languages
English (en)
Inventor
Takuya Tsunoda
Hideaki Tahara
Shuichi Nakatsuru
Yataro Daigo
Yusuke Nakamura
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of HK1156076A1 publication Critical patent/HK1156076A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
HK11110363.5A 2005-02-25 2011-09-30 Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides HK1156076A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65685705P 2005-02-25 2005-02-25

Publications (1)

Publication Number Publication Date
HK1156076A1 true HK1156076A1 (en) 2012-06-01

Family

ID=36570330

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11110363.5A HK1156076A1 (en) 2005-02-25 2011-09-30 Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
HK11110367.1A HK1156077A1 (en) 2005-02-25 2011-09-30 Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK11110367.1A HK1156077A1 (en) 2005-02-25 2011-09-30 Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides

Country Status (10)

Country Link
US (2) US7847060B2 (xx)
EP (3) EP2325306B1 (xx)
JP (5) JP4461179B2 (xx)
DE (1) DE602006021283D1 (xx)
DK (2) DK2325305T3 (xx)
ES (3) ES2459466T3 (xx)
HK (2) HK1156076A1 (xx)
PL (2) PL2325305T3 (xx)
PT (2) PT2325305E (xx)
WO (1) WO2006090810A2 (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
JP2010512730A (ja) * 2006-12-13 2010-04-30 オンコセラピー・サイエンス株式会社 肺癌の腫瘍マーカーおよび治療標的としてのｔｔｋ
AU2012261725B2 (en) * 2007-02-21 2014-11-27 Oncotherapy Science, Inc. Peptide vaccines for cancers expressing tumor-associated antigens
TWI596109B (zh) * 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
WO2009016691A1 (en) * 2007-07-30 2009-02-05 Oncotherapy Science, Inc. Cancer associated gene ly6k
KR101561175B1 (ko) 2007-08-20 2015-10-16 온코세라피 사이언스 가부시키가이샤 Ｃｄｈ３ 펩티드 및 이를 포함하는 의약제
TWI543767B (zh) * 2008-08-19 2016-08-01 腫瘤療法 科學股份有限公司 Ｈｉｇ２與ｕｒｌｃ１０抗原決定位胜肽以及含此胜肽之疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CN104086625B (zh) 2008-10-22 2016-08-31 肿瘤疗法科学股份有限公司 Rab6kifl/kif20a表位肽及包含它的疫苗
TWI539160B (zh) 2008-12-05 2016-06-21 腫瘤療法 科學股份有限公司 Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗
CN104193816A (zh) 2008-12-24 2014-12-10 肿瘤疗法科学股份有限公司 C1orf59肽及包含它的疫苗
MX2011008917A (es) * 2009-03-04 2011-09-09 Oncotherapy Science Inc Peptidos vangl1 y vacunas que incluyen los mismos.
TW201100090A (en) * 2009-04-01 2011-01-01 Oncotherapy Science Inc C6orf167 peptides and vaccines containing the same
TW201102081A (en) * 2009-05-11 2011-01-16 Oncotherapy Science Inc TTK peptides and vaccines including the same
CN102481333B (zh) * 2009-09-03 2017-07-14 东丽株式会社 免疫诱导剂
TW201124530A (en) * 2009-12-01 2011-07-16 Oncotherapy Science Inc IMP-3 oligopeptides and vaccines including the same
TW201200525A (en) * 2009-12-04 2012-01-01 Oncotherapy Science Inc MYBL2 peptides and vaccines containing the same
TW201211250A (en) * 2010-09-07 2012-03-16 Oncotherapy Science Inc VANGL1 peptides and vaccines including the same
KR20140138900A (ko) * 2012-03-09 2014-12-04 온코세라피 사이언스 가부시키가이샤 펩티드를 포함한 의약 조성물
WO2014010232A1 (en) 2012-07-10 2014-01-16 Oncotherapy Science, Inc. Ly6k epitope peptides for th1 cells and vaccines containing the same
TWI627182B (zh) * 2013-05-24 2018-06-21 腫瘤療法 科學股份有限公司 對於ｔｈ１細胞之ｉｍｐ－３抗原決定位胜肽及含此之疫苗
US10576097B2 (en) 2014-08-04 2020-03-03 Oncotherapy Science, Inc. URLC10-derived peptide and vaccine containing same
CN106715461B (zh) 2014-08-04 2020-11-24 肿瘤疗法科学股份有限公司 Koc1衍生的肽和包含它们的疫苗
EP3207936B1 (en) * 2014-11-18 2021-04-21 Shionogi & Co., Ltd. Stable peptide composition
WO2021060343A1 (ja) * 2019-09-24 2021-04-01 オンコセラピー・サイエンス株式会社 Ｕｒｌｃ１０由来ペプチドまたはｄｅｐｄｃ１由来ペプチドを認識するヒトｔ細胞が発現するｔ細胞受容体

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5922687A (en) 1995-05-04 1999-07-13 Board Of Trustees Of The Leland Stanford Junior University Intracellular delivery of nucleic acids using pressure
CA2225553A1 (en) 1995-08-03 1997-02-20 Rijksuniversiteit Te Leiden Cell derived antigen presenting vesicles
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
JP2000516090A (ja) 1996-07-26 2000-12-05 スローン―ケッタリング インスティチュート フォー キャンサー リサーチ 遺伝子的免疫化のための方法と試薬
WO1998045428A1 (de) 1997-04-07 1998-10-15 Roche Diagnostics Gmbh Fanconi-gen ii
ATE213268T1 (de) 1997-04-07 2002-02-15 Roche Diagnostics Gmbh Fanconi-gen ii
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US6255055B1 (en) 1998-03-09 2001-07-03 Wisconsin Alumni Research Foundation c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence
US20030236209A1 (en) * 1998-03-18 2003-12-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030045491A1 (en) 2001-02-23 2003-03-06 Christoph Reinhard TTK in diagnosis and as a therapeutic target in cancer
AU2001251084A1 (en) 2000-03-29 2001-10-08 Diadexus, Inc. Polynucleotides and polypeptides as well as methods for diagnosing and treating lung cancer
MXPA03003151A (es) 2000-10-13 2003-08-19 Eos Biotechnology Inc Metodos de diagnostico de cancer de prostata, composiciones y metodos para seleccionar moduladores de cancer de prostata.
WO2002036142A2 (en) * 2000-11-03 2002-05-10 University Of Vermont And State Agricultural College Compositions for inhibiting grb7
CA2438092C (en) 2001-02-21 2011-08-09 Chiron Corporation Ttk in diagnosis and as a therapeutic target in cancer
WO2002086443A2 (en) 2001-04-18 2002-10-31 Protein Design Labs, Inc Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
US7189507B2 (en) * 2001-06-18 2007-03-13 Pdl Biopharma, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
EP1446507A2 (en) 2001-10-31 2004-08-18 Pfizer Products Inc. Therapeutics and diagnostics for disorders of erythropoiesis
CA2467433A1 (en) 2001-11-13 2003-05-22 Eos Biotechnology, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
WO2003042661A2 (en) 2001-11-13 2003-05-22 Protein Design Labs, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
US20030232350A1 (en) * 2001-11-13 2003-12-18 Eos Biotechnology, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
WO2003062395A2 (en) 2002-01-18 2003-07-31 Bristol-Myers Squibb Company Predictor sets for tyrosine kinase pathways
SI1513934T1 (sl) * 2002-06-06 2011-06-30 Oncotherapy Science Inc Geni in polipeptidi, povezani s humanimi raki kolona
CN103951745A (zh) * 2002-09-12 2014-07-30 肿瘤疗法科学股份有限公司 Kdr肽和包括该肽的疫苗
US20060024692A1 (en) 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
DE602004032235D1 (de) 2003-06-09 2011-05-26 Corixa Corp Dna-vektoren
WO2005073374A1 (ja) * 2004-01-29 2005-08-11 Dainippon Sumitomo Pharma Co., Ltd. 新規腫瘍抗原蛋白質及びその利用
US20050186610A1 (en) 2004-02-20 2005-08-25 Yeon-Su Lee Breast cancer related protein, gene encoding the same, and method of diagnosing breast cancer using the protein and gene
DE602005025998D1 (de) 2004-03-23 2011-03-03 Oncotherapy Science Inc Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs
JPWO2006093337A1 (ja) 2005-03-03 2008-08-07 武田薬品工業株式会社 癌の予防・治療剤
JP2010512730A (ja) * 2006-12-13 2010-04-30 オンコセラピー・サイエンス株式会社 肺癌の腫瘍マーカーおよび治療標的としてのｔｔｋ
WO2009016691A1 (en) * 2007-07-30 2009-02-05 Oncotherapy Science, Inc. Cancer associated gene ly6k
TW201008574A (en) * 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same

Also Published As

Publication number Publication date
HK1156077A1 (en) 2012-06-01
ES2459466T3 (es) 2014-05-09
JP2009173662A (ja) 2009-08-06
JP2009173661A (ja) 2009-08-06
US8614176B2 (en) 2013-12-24
EP1853703A2 (en) 2007-11-14
EP2325305A1 (en) 2011-05-25
JP4493054B2 (ja) 2010-06-30
EP2325306B1 (en) 2014-02-12
DK2325306T3 (en) 2014-03-03
WO2006090810A2 (en) 2006-08-31
DE602006021283D1 (de) 2011-05-26
DK2325305T3 (en) 2014-03-03
WO2006090810A3 (en) 2007-03-29
JP2010143924A (ja) 2010-07-01
US20110027302A1 (en) 2011-02-03
PT2325305E (pt) 2014-04-29
JP2008530975A (ja) 2008-08-14
JP4493053B2 (ja) 2010-06-30
EP2325306A1 (en) 2011-05-25
PT2325306E (pt) 2014-04-29
ES2364670T3 (es) 2011-09-12
PL2325305T3 (pl) 2014-07-31
EP1853703B1 (en) 2011-04-13
EP2325305B1 (en) 2014-02-12
JP2009173660A (ja) 2009-08-06
JP4461179B2 (ja) 2010-05-12
US7847060B2 (en) 2010-12-07
PL2325306T3 (pl) 2014-07-31
US20090202576A1 (en) 2009-08-13
ES2459492T3 (es) 2014-05-09

Similar Documents

Publication Publication Date Title
HK1156077A1 (en) Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
HK1171025A1 (en) Peptide vaccines for cancers expressing depdc1 polypeptides depdc1
GB0524788D0 (en) Polypeptides
EG25313A (en) Improved dry powder inhaler.
GB0520794D0 (en) Inhaler
ZA200709046B (en) Breath actuated inhaler
GB0518355D0 (en) An inhaler
EP1859828A4 (en) INHALER
GB0508863D0 (en) Peptide
IL186880A0 (en) Evolved interferon alpha polypeptides
GB0500677D0 (en) Dry powder inhaler
ZA200610812B (en) Keratin-binding polypeptides
EP1765392A4 (en) POLYPETPIDES INDUCING APOPTOSIS
GB0524194D0 (en) Respirable powders
IL196292A0 (en) Csf3r polypeptides, their preparation and uses thereof
GB0505949D0 (en) Polypeptides
GB0526120D0 (en) Therapeutic peptides
GB0526019D0 (en) Peptides
GB0516527D0 (en) Peptides
GB0403491D0 (en) Polypeptides, methods and means
GB0510091D0 (en) Inhaler
EP1881843A4 (en) KINASEPEPTIDES AND ANTIBODIES
GB0511861D0 (en) Proteins
ATE505536T1 (de) Peptid-impfstoff für lungenkrebs, der ttk polypeptide exprimiert
GB0508866D0 (en) Soluble polypeptide

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230217